| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 02/02/2006 | US20060024324 Glutamate-rich protein (GLURP) genetically coupled to plasmodium falciparum merozoite surface protein 3 (MSP3) for use as tool in preventing malarial infection; Antimalarial agents; parasiticides |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | CA2575272A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 02/01/2006 | EP1621547A1 C of malarial pre-erythrocytic stage polypeptide molecules and lipids |
| 02/01/2006 | EP1115849B1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP0956040B1 Stimulation of host defense mechanisms against viral challenges |
| 02/01/2006 | EP0898478B1 Stimulation of host defence mechanisms against tumors |
| 02/01/2006 | CN1239181C Chinese patent medicine for treating apoplexy |
| 01/31/2006 | US6992099 For controlling parasites in or on an animal |
| 01/31/2006 | US6991776 Halogenated xanthene or halogenated xanthene derivative; cancer treatment |
| 01/26/2006 | WO2006009119A1 Process for production of polysubstituted cyclobutanes and polysubstituted cyclobutenes |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections |
| 01/26/2006 | US20060020013 Control of arthropods in animals |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019246 Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases |
| 01/26/2006 | US20060018984 Intravaginal washing agent |
| 01/26/2006 | US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1 |
| 01/25/2006 | EP1617731A2 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 01/25/2006 | CN1724073A Suspension-aid agent for vaccine of coccidiosis |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014760 Compounds and methods of use to treat infectious diseases |
| 01/19/2006 | US20060014716 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013811 Methods of treating IgE-associated disorders and compositions for use therein |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1616564A2 Manipulation of nitrosative stress for treating microbes and helminths |
| 01/18/2006 | CN1723037A Methods and compositions for promoting the maturation of monocytes |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236798C External medicine for treating bone tuberculosis |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6986908 Delta-aminolevulinic acid for prevention and treatment of infection by pathogenic microorganisms and parasite |
| 01/17/2006 | CA2351829C Macrolide antibiotics |
| 01/12/2006 | US20060009414 Protecting a muscarinic acetylcholine receptor in patient; prevent tissue damage, increasing the efficacy of a therapeutic agent |
| 01/12/2006 | US20060009413 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions |
| 01/12/2006 | CA2571440A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 01/11/2006 | EP1614414A2 Compositions comprising a copper compound for treatment of mammalian diseases |
| 01/11/2006 | EP1613639A1 Avermectins substituted in the 4'' and 4´-positions having pesticidal properties |
| 01/11/2006 | EP1613299A2 Combination product for controlling insect pests |
| 01/11/2006 | EP1399130A4 Emulsion and dispersion formulations and method |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1294402B1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/11/2006 | EP1235925B1 Feeding assay for identifying nematicidal compounds |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | CN1720235A 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 01/11/2006 | CN1718236A Epidemic prevention method for domestic birds using traditional Chinese herbs and formula thereof |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235631C Antiscolic for preventing and treating eel enteric and internal parasite |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984640 Antiparasitic artemisinin derivatives (endoperoxides) |
| 01/10/2006 | CA2372206C Novel crystalline forms of a macrolide antibiotic |
| 01/10/2006 | CA2157590C Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002905 Mutant forms of EtxB and CtxB and their use as carriers |
| 01/04/2006 | EP1611892A2 Pharmaceutical compositions comprising drospirenone |
| 01/04/2006 | EP1611111A2 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1292306B1 A combination kit used in the treatment of malaria containing chloroquine and bulaquine |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | CN1714865A Natural molecular submit vaccine for anti-Japanese snail fever |
| 01/04/2006 | CN1714788A Tinidazole powder injection and its preparing method |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234695C N-alkoxyalkyl-substituted benzimidazoles and use thereof as active agent against parasitic protozoans |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234364C Gel composition for killing parasites |
| 01/03/2006 | US6982285 Control of parasites attached to skin of fish |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982247 isolated peptide or protein of given sequence derived from the mucus of the foot sole of Archachatina marginata, a West-African snail; use against viral, bacterial or fungal infections |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 12/29/2005 | US20050288259 Composition |
| 12/29/2005 | US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 12/29/2005 | US20050287166 Malarial pre-erythrocytic stage polypeptide molecules |
| 12/29/2005 | US20050287157 Dry formulation for transcutaneous immunization |
| 12/29/2005 | CA2570534A1 Anti-parasitic uses of borinic acid complexes |
| 12/28/2005 | EP1609362A2 Non-systemic control of parasites |
| 12/28/2005 | EP1095042B1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 12/28/2005 | EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors |
| 12/28/2005 | CN1233234C (S)-Enantiomer enriched tipronil composition |
| 12/27/2005 | US6979747 Antioxidants, preparation processes and their uses |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/22/2005 | WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 12/22/2005 | US20050282889 Intracorporeal medicaments for photodynamic treatment of disease |
| 12/22/2005 | US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis |
| 12/22/2005 | US20050282804 Process for preparing 10alpha-[4'-(S,S-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin |